Literature DB >> 33067250

Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis.

Hao Qin1,2, Zhijuan Lin3, Elizabeth Vásquez4, Xiao Luan2, Feifei Guo2, Luo Xu2.   

Abstract

BACKGROUND: Uterine fibroids (UFs) are the most common form of sex steroid hormone-dependent benign tumours that grow in the walls of the uterus. Several observational studies have examined the association between obesity and the risk of UFs, but findings are inconsistent. The objective of this systematic review and meta-analysis is to further examine the association of obesity with the risk/prevalence of UFs.
METHODS: A literature search was performed in three databases (PubMed, EMBASE and Web of Science) from 1 January 1992 to 30 May 2020. We used random-effect models to calculate the pooled ORs with corresponding 95% CIs. Additionally, we performed a dose-response meta-analysis to analyse the effect of body mass index (BMI), weight change since age 18, waist-to-hip ratio and waist circumference on the risk/prevalence of UFs.
RESULTS: A total of 22 articles, covering 24 studies including 325 899 participants and 19 593 cases, were selected based on our inclusion criteria. We found a positive association between obesity and the risk/prevalence of UFs (OR, 1.19; 95% CI, 1.09 to 1.29). Among participants with the highest BMI, the pooled OR was 1.19 (1.09 to 1.31) when compared to participants with normal BMI. For weight change since age 18, the pooled OR (95% CI) of UFs was 1.26 (1.12 to 1.42) among the highest change group when compared with no change. Additionally, our meta-analysis indicated the relationship of BMI with risk of UFs to be an inverse J-shaped pattern.
CONCLUSIONS: The results of this meta-analysis suggest that obesity may increase the risk/prevalence of UFs, and the association is non-linear. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Year:  2020        PMID: 33067250     DOI: 10.1136/jech-2019-213364

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  7 in total

1.  Increased Expression of Fibroblast Activation Protein is Associated with Autophagy Dysregulation and Oxidative Stress in Obese Women with Uterine Fibroids.

Authors:  Nashwa Maghraby; Amira M El Noweihi; Nagla T El-Melegy; Nashwa A M Mostafa; Ahmed M Abbas; Heba E M El-Deek; Eman Radwan
Journal:  Reprod Sci       Date:  2021-11-29       Impact factor: 3.060

Review 2.  Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.

Authors:  Mohamed Ali; Mohamed Raslan; Michał Ciebiera; Kornelia Zaręba; Ayman Al-Hendy
Journal:  Expert Opin Drug Saf       Date:  2021-10-20       Impact factor: 4.250

3.  Association of Vitamin D Anabolism-Related Gene Polymorphisms and Susceptibility to Uterine Leiomyomas.

Authors:  Shangdan Xie; Mengying Jiang; Hejing Liu; Fang Xue; Xin Chen; Xueqiong Zhu
Journal:  Front Genet       Date:  2022-06-20       Impact factor: 4.772

4.  Epidemiology of uterine fibroid in black African women: a systematic scoping review.

Authors:  Imran O Morhason-Bello; Clement A Adebamowo
Journal:  BMJ Open       Date:  2022-08-03       Impact factor: 3.006

Review 5.  Advances and development of prostate cancer, treatment, and strategies: A systemic review.

Authors:  Sana Belkahla; Insha Nahvi; Supratim Biswas; Irum Nahvi; Nidhal Ben Amor
Journal:  Front Cell Dev Biol       Date:  2022-09-09

6.  Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass.

Authors:  Julie Abildgaard; Thorkil Ploug; Elaf Al-Saoudi; Thomas Wagner; Carsten Thomsen; Caroline Ewertsen; Michael Bzorek; Bente Klarlund Pedersen; Anette Tønnes Pedersen; Birgitte Lindegaard
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

7.  Midlife Urinary Phthalate Metabolite Concentrations and Prior Uterine Fibroid Diagnosis.

Authors:  Diana C Pacyga; Brad A Ryva; Romana A Nowak; Serdar E Bulun; Ping Yin; Zhong Li; Jodi A Flaws; Rita S Strakovsky
Journal:  Int J Environ Res Public Health       Date:  2022-02-26       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.